STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 5.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $125,000 | -92.9% | 11,802 | -93.6% | 0.00% | -100.0% |
| Q4 2018 | $1,761,000 | -38.0% | 185,395 | +8.3% | 0.00% | 0.0% |
| Q3 2018 | $2,841,000 | -0.4% | 171,120 | -3.7% | 0.00% | 0.0% |
| Q2 2018 | $2,853,000 | -14.1% | 177,731 | -18.1% | 0.00% | 0.0% |
| Q1 2018 | $3,322,000 | -1.9% | 217,129 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,387,000 | +39.2% | 217,129 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $2,434,000 | +119.7% | 219,252 | +82.0% | 0.00% | 0.0% |
| Q2 2017 | $1,108,000 | +88.1% | 120,477 | +74.9% | 0.00% | – |
| Q1 2017 | $589,000 | -30.9% | 68,899 | -13.6% | 0.00% | – |
| Q4 2016 | $853,000 | -3.7% | 79,719 | -2.6% | 0.00% | – |
| Q3 2016 | $886,000 | +281.9% | 81,819 | +138.3% | 0.00% | – |
| Q2 2016 | $232,000 | +241.2% | 34,337 | +133.9% | 0.00% | – |
| Q1 2016 | $68,000 | – | 14,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |